Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 1, 1997, Pages 31-39

  Prestidge, Bradley R ^a   Hoak, David C ^b   Grimm, Peter D ^c,d   Ragde, Haakon ^d   Cavanagh, William ^d   Blasko, John C ^c,d  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b Pathology Associates Inc   (United States)

^c Northwest Neuroscience Institute   (United States)

^d PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Interstitial brachytherapy; Postimplant biopsy; Prostate cancer

Indexed keywords

IODINE 125; PALLADIUM; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BRACHYTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING;

BIOPSY; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; NEOPLASM PROTEINS; NEOPLASM STAGING; PALLADIUM; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOISOTOPES;

EID: 0031051524     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00390-2     Document Type: Article

References (34)

1. American Joint Committee on Cancer. In: Manual for staging of cancer, 4th ed. Philadelphia, PA: Lippincott Co; 1992:181-186.
2. 125Iodine implantation for stage T1/T2 prostatic carcinoma. J. Urol. 154:1096-1099; 1995.
3. 192iridium implantation and external beam irradiation for carcinoma of the prostate. J. Urol. 135:722-726; 1986.
4. Bostwick, D. G.; Egbret, B. M.; Fajardolf, L. F. Radiation injury of the normal and neoplastic prostate. Am. J. Surg. Pathol. 6:541-551; 1982.
5. Bulmer, M.G. Principles of statistics. Edinburgh, Scottland: Oliver and Boyd; 1967.
6. Cox, J. D.; Kline, R. W. The lack of prognostic significance of biopsies after radiotherapy for prostatic cancer. Semin. Urol. 1:237-242; 1983.
7. Cox, J. D.; Stoffel, T. J. The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate. Cancer 40:156-160; 1977.
8. Crook, J. M.; Perry, G. A.; Robertson, S.; Esche, B. A. Routine prostate biopsies following radiotherapy for prostate cancer: Results for 226 patients. Urology 45:624-631; 1995.
9. Freiha, F. S.; Bagshaw, M. A. Carcinoma of the prostate: Results of postirradiation biopsy. Prostate 5:19-25; 1984.
10. Gehan, E. A. A generalized Wilcoxon test for comparing arbitrarily singly sensored samples. Biometrka 52:202-233; 1965,
11. Gerdes, J.; Becker, M.; Key. G. Immunohistological detection of tumor growth fraction (Ki-67 antigen) in formalin and-fixed and routinely processed tissues. J. Pathol. 168:85-87; 1992.
12. Grimm, P. D.; Blasko, J. C.; Ragde, H. Ultrasound-guided transperineal implantation of Iodine-125 and palladium-103 for the treatment of early stage prostate cancer. Atlas Urol. Clin North Am. 2(2): 113-125; 1994.
13. 125I implantation for carcinoma of the prostate. Further follow-up of first one hundred cases. Urology 20:591-597; 1982.
14. Helpap, B. Histopathlogical effects of radiotherapy. In: Bruggmosur, B. D.; Sommercamp, H.; Mould, R. F., eds. Brachytherapy of prostate cancer, proceeding of international symposium, interstitial radiotherapy of prostate cancer: The state of the art. 30 Nov-1 Dec 1990. Great Britain: BPCC Hazell Books: 1991:41-52.
15. Kabalin, J. N.; Hodge, K. K.; McNeal, J. E.; Freiha, F. S.; Stamey, T. A. Identification of residual cancer in the prostate following radiation therapy: Role of transrectal ultrasound guided biopsy and prostate specific antigen. J. Urol. 142:326-331; 1989.
16. Kiesling, V. J.; McAninch, J. W.; Goebel, J. L. External beam radiotherapy for adenocarcinoma of the prostate: A clinical follow-up. J. Urol. 142:851-854; 1980.
17. Klein, A. F.; Ali, M. M.: Marks, S. E.; Hackler, R. H. Bilateral pelvic lymphadenectomy, iridium 192 template, and external beam therapy for localized prostatic carcinomas: Complications and results. South. Med. J. 81:27-34: 1988.
18. Kuban, D. A.; El-Mahdi, A. M.; Schellhammer, P. F. The significance of post irradiation prostate biopsy with long-term follow-up. Int. J. Radiol. Oncol. Biol. Phys. 24:409-414; 1992.
19. Lange, P. H.; Ercole, C. J.; Lightner. D, J.; Fraley, E. E.; Vessella, R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J. Urol. 141:873-876; 1989.
20. Ling, C. C. Permanent implant using Au-198, Pd-103, I-125: Radiobiological consideration based on the linear quadratic model. Int. J. Radiol. Oncol. Biol. Phys. 23:81-86; 1992.
21. 192iridium template irradiation plus supplemental external beam radiation. J Urol. 147(3):922-925; 1992.
22. Mellinger, G. T.; Gleason, D.; Bailar, J. The histology and prognosis in carcinoma of the prostate. Front. Radiat. Ther. Oncol. 9:267-273; 1967.
23. Mostofi, F. K.; Davis, C. J.; Sesterhan, IA, Pathology of carcinoma of the prostate. Cancer Suppl. 70:235-253; 1992.
24. Mostofi, F. K.; Sesterhan, I. A.; Davis, C. J. A pathlogist's view of prostatic carcinoma. Cancer Suppl. 71:906-932; 1993.
25. Nachtsheim, D. A.; McAninch, J. W.; Stoutzman, R. E. Latent residual tumor following external radiotherapy for prostate adenocarcinoma. J. Urol. 120:312-314; 1978.
26. Nemoto, R.; Kawamurah, H.; Miyakawa, I.; Uchida, K.; Hattori, K.; Koiso, K.; Hariada, M. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA)/ cyclin in human adenocarcinoma. J. Urol. 149:165-169; 1993.
27. Paulson, D. F.; Moul, J. W.; Walther, P. J. Radical prostatectomy for clinical stage T1-2 NOMO prostatic adenocarcinoma long-term results. J. Urol. 144:1180-1184; 1990.
28. Prestidge, B. R.; Kaplan, I.; Cox, R. S.; Bagshaw, M. A. Predictors of survival after a positive postirradiation prostate biopsy. Int. J. Radiol. Oncol. Biol. Phys. 28:17-22; 1994.
29. Prestidge, B. R.; Kaplan, I.; Cox, R. S.; Bagshaw, MA. The clinical significance of a positive postirradiation biopsy without metastases. Int. J. Radiol. Oncol. Biol. Phys. 24:403-408; 1992.
30. 125iodine seed implantation and external irradiation for carcinoma of the prostate. J. Urol. 127:699-705; 1982.
31. Scardino, P. T.; Wheeler, T. M. Local control of prostate cancer with radiotherapy: Frequency and prognostic significance of positive results after postirradiation prostate biopsy. Natl. Cancer Inst. Monogr. 7:95-103; 1988.
32. Scardino, P. T.; Wheeler, T. M. Prostatic biopsy after irradiation therapy for prostate cancer. Urology 25(Suppl. 2):39-47; 1985.
33. Schellhammer, P. F.; Ladaga, L. E.; El Mahdi, A. Histological characteristics of prostatic biopsies after 125 iodine implantation. J. Urol. 123:700-706: 1980.
34. Zeitman, A. L.; Coen. J. J.; Shipley, W. U.; Willett, C. G.; Efird, J. T, Radical radiation therapy in the management of prostatic adenocarcinoma: The initial prostate specific anti-gen value is a predictor of treatment outcome. J. Urol. 151:640-645; 1994.